IUG Intelligent Ultrasound Group Plc

TIDMIUG

RNS Number : 6690U

Intelligent Ultrasound Group PLC

27 November 2023

27 November 2023

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Group" or the "Company")

Update regarding Nominated Adviser and Broker

Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound company, specialising in artificial intelligence (AI) software and simulation, announces that, following the completion of the all-share merger between Cavendish Securities plc (previously named Cenkos Securities plc) and Cavendish Financial plc (previously named finnCap Group plc), and as a consequence of internal reorganisation within the Cavendish Group, the Company has changed its Nominated Adviser and Broker from Cavendish Securities plc to Cavendish Capital Markets Limited.

For further information, please contact:

 
Intelligent Ultrasound Group plc                           www.intelligentultrasound.com 
Stuart Gall, CEO                                                Tel: +44 (0)29 2075 6534 
Helen Jones, CFO 
 
Cavendish Capital Markets Limited - Nominated Adviser and Broker 
Giles Balleny/Dan Hodkinson (Corporate                          Tel: +44 (0)20 7220 0500 
 Finance) 
Michael Johnson/Julian Morse (Sales) 
 Nigel Birks (ECM) 
 
TB Cardew - PR Advisors                               Intelligentultrasound@tbcardew.com 
 Ed Orlebar                                                      Tel: +44 (0)7738 724630 
Allison Connolly                                                 Tel: +44 (0)7587 453955 
Emma Pascoe-Watson                                               Tel: +44 (0)7774 620415 
Hero Kurzeja                                                     Tel: +44 (0)7827 130430 
 

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the US, the Group has two revenue streams:

Simulation

Real-time hi-fidelity ultrasound education and training through simulation. Our main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid-19 module and the new BabyWorks Neonate and Paediatric training simulator. To date over 1,500 simulators have been sold to over 750 medical institutions around the world.

Clinical AI software

Deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare's SonoLyst software that is incorporated in their Voluson Expert 22 and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.

www.intelligentultrasound.com

NOTE: ScanNav Anatomy PNB is CE approved and cleared for sale in the US by the FDA, but is not available for sale in any other territory requiring government approval for this type of product.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

UPDBQLFLXFLZFBQ

(END) Dow Jones Newswires

November 27, 2023 02:00 ET (07:00 GMT)

Intelligent Ultrasound (LSE:IUG)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Intelligent Ultrasound (LSE:IUG)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024